Piper Sandler: 'We Strongly Encourage Investors to Buy the Stock'; Kestra Medical Technologies (KMTS) PT Raised

December 12, 2025 7:59 AM EST Send to a Friend
Piper Sandler analyst Matt O'Brien raised the price target on Kestra Medical Technologies (NASDAQ: KMTS) to $30.00 (from $27.00) while ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login